Lot CJI433 Save $33.75 CJC-1295 No DAC + Ipamorelin 10mg

Research peptide · Lyophilized

CJC-1295 No DAC + Ipamorelin 10mg

CJC-1295 No DAC + Ipamorelin — USA Made, ≥99% Purity

4.9 177 verified reviews

Balanced 10mg blend: CJC-1295 No DAC 5mg + Ipamorelin 5mg
USA manufactured in GMP-certified California and Arizona laboratory facilities
≥99% component purity target with HPLC, mass spectrometry, and combined batch COA

$134.99 $168.74 Save $33.75

Manufactured in a GMP facility · Independently tested · Batch COA

Dispatched from a US warehouse within 48 hours, tracked

Certificate of analysis for lot CJI433 below

Disclaimer

For research purposes only. Not intended for human consumption, medical use, diagnosis, treatment, or prevention of disease.

Specifications

Lot CJI433

Purity target

≥99%

≥99% per peptide component (3rd-Party HPLC Tested)

Components

CJC-1295 No DAC: 3,367.95 g/mol; Ipamorelin: 711.9 g/mol

Vial content

10 MG

Lyophilized Powder

Sequences

CJC-1295 No DAC: Y-(D-Ala)-DAIFTQSYRKVLAQLSARKLLQDILSR-NH2; Ipamorelin: Aib-His-D-2-Nal-D-Phe-Lys-NH2

CAS: CJC-1295 No DAC: 446036-97-1; Ipamorelin: 170851-70-4
Molecular mass: CJC-1295 No DAC: 3,367.95 g/mol; Ipamorelin: 711.9 g/mol
Purity target: ≥99% per peptide component (3rd-Party HPLC Tested)
Form: Lyophilized Powder
Origin: Manufactured, Formulated & Packaged in CA/AZ, USA
Storage: Store at -20°C (Freeze) or 2–8°C (Refrigerated) protected from light

What is CJC-1295 No DAC + Ipamorelin?

This research blend combines 5mg of CJC-1295 Without DAC with 5mg of Ipamorelin. CJC-1295 No DAC is a 29-residue GHRH analog, while Ipamorelin is a modified five-residue ghrelin-receptor agonist.

The blend is designed for laboratory investigation of two distinct upstream signaling routes connected with the growth-hormone axis. The ingredients remain separate molecules, and co-formulation does not prove a clinical benefit or make the product an approved therapy.

How It Works

CJC-1295 No DAC activates GHRH receptors: This supports study of cAMP-dependent pituitary signaling.

Ipamorelin activates GHS-R1a: The ghrelin-receptor pathway provides a second experimental signal associated with growth-hormone release.

Two pathways can be observed together: Researchers can measure how GHRH-receptor and GHS-R1a signaling interact in an appropriate model.

Analytical data

Every lot, on the record

Independent third-party HPLC evaluates the purity target, while mass spectrometry confirms molecular identity. Both results are documented in one combined, batch-specific Certificate of Analysis.

Purity (HPLC-UV)

99.95%

Net content

Ipamorelin - 5.60 mg CJC-1295 - 5.48 mg

Reported

2026-06-01

Identity (LC-MS): Confirmed
Appearance: White Lyophilized Powder

HPLC MS

Analyte	Method	Result
Identity	LC-MS	Ipamorelin/CJC-1295
Purity	HPLC-UV	99.95%
Net Content		Ipamorelin - 5.60 mg, CJC-1295 - 5.48 mg

Chromatogram

Mass confirmation

Download COA (PDF)

Why Source from 321 Peptides?

Both peptides made domestically.

The components are synthesized and finished in GMP-certified California and Arizona facilities, with no overseas or Mexico sourcing.

Correct ratio, confirmed identities.

Third-party HPLC evaluates each ≥99% purity target and mass spectrometry checks both expected molecules. One batch-specific COA documents the 5mg + 5mg blend.

Lyophilized as one research vial.

Freeze-drying helps preserve both peptides during storage and transit. Fast domestic fulfillment keeps the chain of custody direct.

Lot history 4 released lots

Every batch released under this compound, with the figure reported for each.

Lot	Reported	Purity	Net content	COA
CJI433	2026-06-01	99.95%	Ipamorelin - 5.60 mg, CJC-1295 - 5.48 mg	PDF
CJ-48928 Superseded	2026-05-12	99.64%	10.04 mg	Pending
CJ-49505 Superseded	2026-04-30	99.88%	10.05 mg	Pending
CJ-50082 Superseded	2026-02-25	99.71%	10.06 mg	Pending

Frequently Asked Questions

What is in the CJC-1295 and Ipamorelin 10mg blend?

Each vial contains CJC-1295 Without DAC 5mg and Ipamorelin 5mg. The total research-material content is 10mg.

How do CJC-1295 No DAC and Ipamorelin differ?

CJC-1295 No DAC is a GHRH-receptor agonist, while Ipamorelin acts through the ghrelin receptor GHS-R1a. The blend lets researchers examine both signaling routes together.